{
    "2018-07-26": [
        [
            {
                "time": "2018-07-26",
                "original_text": "Allergan Reports Strong Revenue Growth and Q2 2018 Earnings",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Strong Revenue Growth",
                        "Q2 2018 Earnings"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "Celgene Raises Revenue Guidance after Solid Growth in Q2 2018",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Revenue Guidance",
                        "Solid Growth",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "Analysts’ Recommendations for Sanofi Stock before Q2 Results",
                "features": {
                    "keywords": [
                        "Analysts’ Recommendations",
                        "Sanofi",
                        "Q2 Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Q2 Earnings",
                        "Sales Beat",
                        "Stock Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Q2 Earnings",
                        "Buyback Plan"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Q2 Earnings",
                        "Sales Beat",
                        "Estimates",
                        "'18 View Up"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-24",
                "original_text": "LLY Crosses Above Average Analyst Target",
                "features": {
                    "keywords": [
                        "LLY",
                        "Crosses Above",
                        "Average Analyst Target"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Q2 Earnings",
                        "Sales Beat",
                        "Estimates",
                        "'18 View Up"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions",
                "features": {
                    "keywords": [
                        "ABBV",
                        "MRK",
                        "Q2 Earnings",
                        "Key Predictions"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-23",
                "original_text": "Initiating Free Research Reports on Pfizer and Three Other Drug Makers Equities",
                "features": {
                    "keywords": [
                        "Free Research Reports",
                        "Pfizer",
                        "Drug Makers Equities"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "FOCUS-Amgen's new migraine drug hits insurance hurdles",
                "features": {
                    "keywords": [
                        "Amgen",
                        "migraine drug",
                        "insurance hurdles"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}